Sophie Elizabeth Claudel, MD
Clinical Instructor, Medicine
Biography
Dr. Claudel is a Nephrology fellow at Boston Medical Center. She also completed her Internal Medicine residency and chief residency at BMC in the NIH R38-funded Promoting Research in Medical Residency (PRIMER) program. As a clinician-investigator, Dr. Claudel uses large secondary datasets to examine the epidemiology of chronic kidney disease (CKD) at the national level and is simultaneously developing a clinical cohort to characterize Boston-area disparities in CKD progression using geospatial analyses. Her research interests are in preventing CKD progression, understanding the relationships between kidney, cardiovascular, and metabolic conditions, and using implementation science approaches to improve outcomes in CKD. Dr. Claudel is additionally involved in the CURE Consortium, a multinational research group studying CKD of unknown etiology (CKDu) in Central America and India. Dr. Claudel received her MD from Wake Forest University School of Medicine and participated in a year-long clinical research fellowship at the National Institutes of Health during her medical school training.
Other Positions
- Resident Physician, Nephrology, Boston Medical Center
Publications
- Published on 6/3/2024
Claudel SE, Waikar SS, Schmidt IM, Vasan RS, Verma A. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors. Eur J Prev Cardiol. 2024 Jun 03. PMID: 38825979.
Read at: PubMed - Published on 4/23/2024
Claudel SE, Waikar SS. Imprecise, Measure it Twice? Dealing With the Biological Variability of Albuminuria in Diabetes. Am J Kidney Dis. 2024 Jul; 84(1):1-3. PMID: 38661613.
Read at: PubMed - Published on 4/2/2024
Verma A, Schmidt IM, Claudel S, Palsson R, Waikar SS, Srivastava A. Association of Albuminuria With Chronic Kidney Disease Progression in Persons With Chronic Kidney Disease and Normoalbuminuria : A Cohort Study. Ann Intern Med. 2024 Apr; 177(4):467-475. PMID: 38560911.
Read at: PubMed - Published on 3/19/2024
Claudel SE, Waikar SS. Systematic Review of Kidney Injury Biomarkers for the Evaluation of CKD of Uncertain Etiology. Kidney Int Rep. 2024 Jun; 9(6):1614-1632. PMID: 38899184.
Read at: PubMed - Published on 3/6/2024
Claudel SE, Chan M, Scammell MK, Waikar SS. Challenges and Opportunities: Studying CKDu in the United States. Kidney360. 2024 Mar 06; 5(4):607-9. PMID: 38446084.
Read at: PubMed - Published on 1/26/2024
Claudel SE, Powell-Wiley TM. Outcomes Associated With Surgical and Pharmacologic Treatment of Obesity in Heart Failure. Circ Heart Fail. 2024 Feb; 17(2):e011323. PMID: 38275126.
Read at: PubMed - Published on 12/11/2023
Claudel SE, Schmidt IM, Gopal DM, Verma A. Elevated cardiac biomarkers in relatively healthy U.S. adults. Eur J Intern Med. 2024 Mar; 121:152-154. PMID: 38087666.
Read at: PubMed - Published on 12/5/2023
Claudel SE, Verma A. Cardiovascular-kidney-metabolic syndrome: A step toward multidisciplinary and inclusive care. Cell Metab. 2023 Dec 05; 35(12):2104-2106. PMID: 38056429.
Read at: PubMed - Published on 5/25/2023
Claudel SE, Waikar SS, Schmidt IM, Verma A. Kidney Disease-Related Mortality Among Asian Americans. Kidney Med. 2023 Aug; 5(8):100676. PMID: 37576431.
Read at: PubMed - Published on 4/30/2023
Claudel SE, Gandhi M, Patel AB, Verma A. Estimating kidney function in patients with cancer: A narrative review. Acta Physiol (Oxf). 2023 Jun; 238(2):e13977. PMID: 37057998.
Read at: PubMed
View 22 more publications: View full profile at BUMC